|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61K 31/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3630112 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18725258.0 |
| Date of filing the European patent application | 2018-05-25 | |
| (97) | Date of publication of the European application | 2020-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (86) | Number | PCT/EP2018/063785 |
| Date | 2018-05-25 |
| (87) | Number | WO 2018/219807 |
| Date | 2018-12-06 |
| (30) | Number | Date | Country code |
| 17174169 | 2017-06-02 | EP |
| (72) |
HOFF, Sabine , DE
RÖSE, Lars , DE
ZOPF, Dieter , DE
KIESSLING, Fabian , DE
LEDERLE, Wiltrud , DE
DOLESCHEL, Dennis , NL
|
| (73) |
Bayer HealthCare LLC ,
100 Bayer Boulevard, Whippany, NJ 07981,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Regorafenibo ir nivolumabo derinys, skirtas vėžio gydymui |
| COMBINATION OF REGORAFENIB AND NIVOLUMAB FOR TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 8 | 185.00 EUR |
| 2026-05-25 |